A new study led by researchers at Tampere University has mapped genes linked to schizophrenia and uncovered a mechanism that disrupts synaptic plasticity in affected individuals. The researchers ...

Cumulus Neuroscience, a leading innovator in brain health technology for clinical trials, today announced the publication of its latest peer-reviewed paper in Scientific Reports: "A brief visual ...

Psychedelics activate the 5-HT2A receptor, upregulate brain-derived neurotrophic factor, and enhance synaptic plasticity, leading to therapeutic potential for stress and psychiatric disorders.

Source: Design by Gordana Kennedy from CoachPulse using sources from Shutterstock and Canva By Corrie Jonn Block, Ph.D., DBA, and Justin James Kennedy, Ph.D., D.Prof. For the last few years, we’ve ...

Psychedelics—frequently recognized as substances such as LSD, psilocybin, and DMT—not only alter perception, mood, and cognition, but they often cause hallucinations. That said, they have also been ...

This study investigates neurophysiological mechanisms underlying corticospinal excitability and sensorimotor cortical activity in response to neuroplasticity-priming interventions. We use non-invasive ...

In December of 1993, former World Boxing Champion John Famechon (who had sustained severe incapacitating brain injuries in August 1991) began a new, complex multi-movement therapy and rehabilitation ...